Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Follow-up of Subjects Exposed to Lentiviral-based CART-EGFRvIII Gene-modified Cellular Therapy Products in Cancer Studies

NCT02666248 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT02666248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02666248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Follow-up of Subjects Exposed to Lentiviral-based CART-EGFRvIII Gene-modified Cellular Therapy Products in Cancer Studies
Lead sponsor
University of Pennsylvania
Phase
Observational
Overall status
Completed
Start date
May 23, 2016
Completion date
January 27, 2018
Enrollment
3 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

subjects entering into this protocol will be followed for up to 15 years after initial cart-egfrviii infusion